Anti-EGFR Therapy: Incidence, Pathology and Management of Associated Side Effects

This month, Sunil Babu, M.D., Michael Liu, M.D., and Robert G. Lerner, M.D., discuss

CME credit is no longer available for this conference.

Sunil Babu, M.D., Michael Liu, M.D., and Robert G. Lerner, M.D.

Release Date: 06/05/2007

Upon completion of this Cyberounds^®, you should be able to:

Describe the common side effects associated with EGFR inhibition
Discuss the correlation between dermatologic side effects of EGFR inhibition and response to therapy
Discuss the possible mechanisms of dermatologic side effects of EGFR inhibitor therapy
Discuss the common principles of management of dermatologic and non-dermatologic side effects.

Authors: Danilo De Gregorio, PharmD, Ph.D.

Several investigational agents offer hope to patients with AML.

Authors: Mary-Elizabeth M. Percival, M.D., M.S. and Roland B. Walter, M.D., Ph.D., M.S.

While some disorders are more readily apparent than others, not all bleeding is straightforward or has a readily identifiable cause.

Authors: Meera B. Chitlur, M.D.

Despite advances in lung cancer chemotherapy, there is a pressing need for effective lung cancer chemoprevention beyond smoking cessation.

Authors: Robert L. Keith, M.D.

Alcohol Abuse and Cancer